Skip to main content
. 2015 Oct 15;15:148. doi: 10.1186/s12871-015-0131-8

Table 2.

Intervention data, fluid balance and laboratory outcome

CONTROL PRESSURE GDFT P-value
(N = 40) (N = 40) (N = 40)
Length of the procedure (min) 110 (100–120) 105 (90–118) 100 (85–113) 0.06
MAP before anesthesia (mmHg) 119 (15) 113 (17) 114 (19) 0.31
MAP end of procedure (mmHg) 118 (14) 105 (12)bc 103 (18)bc <0.001
HR before anesthesia (beats per minute) 73 (10) 72 (11) 68 (13) 0.20
HR end of procedure (beats per minute) 74 (14) 78 (16)c 77 (14)c 0.34
PPV after induction N/A 7.9 (4.2) % 8.9 (4.5) % 0.36
PPV end of procedure N/A 7.2 (2.4) % 8.2 (3.8) % 0.15
Hypotensive periods intraoperatively 3 (1–5) 2 (1–4) 2 (0–4) 0.09
Ephedrin (number of interventions) 2 (0–3) 0 (0–1)b 0 (0–1)b <0.001
Ephedrin (dose - mg) 10 (0–15) 0 (0–10) 0 (0–10) 0.11
Hemoglobin before anesthesia (g/l) 136 (11) 121 (12) ab 131 (14) <0.001
Hemoglobin end of procedure (g/l) 117 (15) 110 (13) ab 118 (16) 0.03
Lactate end of procedure (mmol/l) N/A 1.2 (0.4) 1.2 (0.6) 0.99
Intraoperative fluid balance
Blood loss (ml) 500 (300–575) 500 (300–600) 400 (300–600) 0.77
Maintenance fluids (crystalloid) (ml) 1500 (1200–1500) 700 (600–750)b 750 (600–900)b <0.001
Bolus fluids (colloid) (ml) 0 (0–500) 440 (100–500)b 400 (0–500)b 0.01
Patients receiving transfusion 5 (13 %) 3 (8 %) 1 (3 %) 0.24
Number of packed blood cells transfused 0 (0–0) 0 (0–0) 0 (0–0) 0.26
Early postoperative fluid balance (24 h)
Blood loss (ml) 735 (400–805) 470 (390–840) 500 (380–678) 0.42
Diuresis (ml) 1300 (1025–1625) 1000 (785–1378)b 1075 (900–1300)b 0.01
Crystalloids (ml) 2525 (2300–2800) 2800 (2300–3150) 2700 (2350–3125) 0.27
Colloids (ml) 0 (0–0) 0 (0–0) 0 (0–0) 0.70
Patients receiving transfusion 17 (43 %) 11 (28 %) 4 (10 %)b 0.01
Number of packed blood cells transfused 0 (0–2) 0 (0–2) 0 (0–0)b 0.01
Hemoglobin (24 h) (g/l) 105 (10) 102 (12) a 110 (14) a 0.01
Lactate (24 h) (mmol/l) N/A 1.6 (0.8) 1.7 (0.8) 0.67

Data are presented as mean (standard deviation), median (interquartil range) or number (proportion)

PPV pulse pressure variation, HR heart rate, MAP mean arterial pressure

a - significant difference between PRESSURE vs. GDFT groups

b - significant difference between protocolled group (GDFT or PRESSURE) vs. CONTROL

c - significant difference against baseline